News

New findings reveal Syfovre may protect central vision in macular degeneration patients, delaying vision loss and enhancing treatment strategies.
Alcon launched Tryptyr, a treatment for the signs and symptoms of dry eye disease, in the U.S. Tryptyr (acoltremon ophthalmic solution 0.003%) is a TRPM8 receptor agonist that showed a “statistically ...
With integrated clinical, lab, and research teams onsite, BostonSight expands its capacity to support trials advancing the ...
MemoCore Supplement Australia is now available Drops Support memory, focus, and clarity naturally with this non-stimulant brain health supplement.
With inflammation being the cause of dry eye in many cases, future treatment will likely target this aspect of dry eye.